Create account

Coverage dated September 24, 2026 to September 26, 2026

Ozempic, Wegovy users sue over rare, permanent blindness

Headline from MLive

Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.

MLive's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

6 articles, oldest first.

  1. End Time Headlines

    Ozempic and Wegovy face numerous lawsuits over rare ‘eye stroke’ linked to vision loss (opens End Time Headlines)

    Published

    End Time Headlines's feed description

    Hundreds of patients are suing the makers of popular GLP-1 weight-loss drugs, alleging the medicines raised their risk of a rare “eye stroke” that can steal sight for good. The lawsuits claim the drugs caused NAION—nonarteritic anterior ischemic optic neuropathy—according to The Wall Street Journal.

  2. MLive

    Ozempic, Wegovy users sue over rare, permanent blindness (opens MLive)

    Published

    MLive's feed description

    Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Related updates

Separate coverage close to this update in time and subject.

Ozempic, Wegovy users sue over rare, permanent blindness | Since Then